Structured Active Follow-up in Postoperative Management of Thyroid
Comparative Effectiveness of Structured Active Follow-up Versus Conventional Passive Follow-up in Postoperative Management of Thyroid: A Prospective Cohort Study
Patients after thyroid cancer surgery face multiple challenges, including recurrence monitoring, medication adjustment, complication management (e.g., hypoparathyroidism, vocal cord dysfunction), and long-term psychosocial adaptation. Studies confirm that standardized long-term follow-up can raise 5-year survival rates to over 90% and significantly reduce disability and mortality in patients with thyroid dysfunction.
Despite the recognized importance of follow-up, conventional practice has major limitations. The traditional model relies on passive patient return visits, either when symptoms appear or at fixed intervals. Adherence is influenced by patients' health awareness, education, geographic distance, finances, and work obligations. Consequently, loss to follow-up and delayed follow-up are common. Clinical data from China show that follow-up adherence drops from less than 60% at one year post-surgery to below 40% at three years. Many patients experience disease progression or treatment delays, increasing their physical and psychological burden, as well as healthcare costs. Physicians face high clinic workloads, fragmented patient information, and difficulty tracking long-term outcomes. Furthermore, conventional follow-up lacks personalized plans-timing, content, and methods are uniform, making it difficult to meet diverse patient needs. Poor communication and delayed information transfer further undermine follow-up quality.
In response, a patient-centered, proactive, structured, and full-cycle health management approach has become a new direction for chronic cancer care. Our hospital has introduced the "Follow-up Package (Proactive Postoperative Follow-up Program)," an innovative model that integrates several scheduled in-person specialty visits, interdisciplinary referral resources, convenient online consultation channels, and an AI-based automated reminder system into an annual service. This proactive model shifts from "passive patient return" to "active hospital-led management." It clarifies follow-up timelines, diversifies service formats, strengthens doctor-patient communication, and creates a seamless, responsive management loop.
For patients, this approach offers clearer management pathways, stronger support, and improved access to care. For the healthcare system, it enables more efficient disease management through optimized resource allocation and early detection of problems. By transforming follow-up from a passive, episodic task into an active, continuous partnership, the program addresses the key shortcomings of conventional models-low adherence, lack of personalization, and poor communication-and holds promise for better clinical outcomes and more sustainable use of medical resources.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Yu Feng
- 电话号码:15183042703
- 邮箱:1350502131@qq.com
学习地点
-
-
Sichuan
-
Chengdu、Sichuan、中国、610041
- 招聘中
- West China Hospital of Sichuan University
-
接触:
- Yu Feng
- 电话号码:15183042703
- 邮箱:1350502131@qq.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Patients aged 18-75 years (including 18 and 75 years)
- Patients who have undergone thyroid surgery (including endoscopic surgery, open surgery, etc.) at this study center
- Patients who are conscious, able to communicate in Chinese, and have the necessary smartphone and internet skills to complete outpatient visits (to meet the online functionality requirements of the active follow-up program)
- Patients who voluntarily agree to participate in the study and are able to sign the informed consent form
Exclusion Criteria:
- Patients with other serious illnesses requiring frequent hospital visits or long-term hospitalization (e.g., advanced malignant tumors, severe heart failure, etc.) that may interfere with the assessment of follow-up adherence
- Patients with anaplastic thyroid cancer or distant metastasis, who have an extremely short life expectancy and cannot complete one year of follow-up
- Patients with cognitive impairment or mental illness who are unable to complete the questionnaires
- Patients who plan to move out of the local area within 2 years after surgery and are unable to complete long-term follow-up
- Patients who are pregnant, lactating, or planning to become pregnant within one year
- Patients currently participating in another clinical study that may interfere with their participation in this study
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Structured Active Follow-up Group
|
Proactive Postoperative Follow-up Program (including scheduled in-person clinic visits, interdisciplinary referrals, online consultation channels, and AI-based automated reminders)
|
|
无干预:Conventional Passive Follow-up Group
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Completion Rate of Scheduled In-Person Clinic Visits
大体时间:1 month postoperatively;3 months postoperatively;6 months postoperatively;12 months postoperatively
|
Compare the proportion of scheduled in-person clinic visits completed within the predefined follow-up time windows (postoperative month 1 ± 7 days, month 3 ± 14 days, month 6 ± 14 days, month 12 ± 30 days) during the first year after surgery between the two groups.
Additionally, calculate separately the proportion of patients in each group who completed the in-person clinic visit within each predefined follow-up time window.
|
1 month postoperatively;3 months postoperatively;6 months postoperatively;12 months postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
TSH suppression target achievement rate
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
Proportion of patients who achieve the TSH suppression goal within the specified measurement time points.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
|
Median time to TSH suppression target achievement
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
The median time to achieve the TSH suppression goal within the specified measurement time points.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
|
Patient Satisfaction Score
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
Assessed using the Client Satisfaction Questionnaire (CSQ-8).
This satisfaction score is assessed only for patients in the intervention group, to understand their level of satisfaction with the active follow-up intervention.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
|
Completion rate and accuracy rate of key examinations
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
Whether the thyroid function tests, serum calcium, parathyroid hormone (PTH) tests, and thyroid ultrasound recommended by clinical guidelines and/or the medical team were completed at the time of postoperative outpatient follow-up visits (yes/no), as well as the proportion of missed or unnecessary (excessive) examinations.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
|
Questionnaire completion rate
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
The proportion of questionnaires completed by patients in both groups at each time point and within one year after surgery.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
|
Timely management rate of post-discharge complications
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
The time to management of thyroid surgery-related complications occurring after hospital discharge will be collected, and the rate of timely management of complications will be compared between the two groups.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
|
Oncological safety
大体时间:1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
The proportion of patients in both groups who develop recurrence or distant metastasis during the follow-up period will be collected.
|
1 month postoperatively; 3 months postoperatively; 6 months postoperatively; 12 months postoperatively
|
合作者和调查者
赞助
出版物和有用的链接
一般刊物
- Graetz I, Hu X, Kocak M, Krukowski RA, Anderson JN, Waters TM, Curry AN, Robles A, Paladino A, Stepanski E, Vidal GA, Schwartzberg LS. Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 3;7(6):e2417873. doi: 10.1001/jamanetworkopen.2024.17873.
- Javidi S, Sadrizadeh S, Sadrizadeh A, Bonakdaran S, Jarahi L. Postoperative complications and long-term outcomes after total and subtotal thyroidectomy: a retrospective study. Sci Rep. 2025 Jan 29;15(1):3705. doi: 10.1038/s41598-024-79860-8.
- Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018 Mar 6;319(9):914-924. doi: 10.1001/jama.2018.0898.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2026 (101)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.